NVS - Novartis AG

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue50,135,00049,386,00050,387,00053,634,000
Cost of Revenue16,958,00017,338,00017,404,00017,345,000
Gross Profit33,177,00032,048,00032,983,00036,289,000
Operating Expenses
Research Development8,510,0008,445,0008,935,0009,086,000
Selling General and Administrative15,000,00014,111,00014,247,00014,993,000
Non Recurring----
Others415,000399,000824,0001,121,000
Total Operating Expenses40,883,00040,293,00041,410,00042,545,000
Operating Income or Loss9,252,0009,093,0008,977,00011,089,000
Income from Continuing Operations
Total Other Income/Expenses Net-253,000-1,276,000-843,0001,183,000
Earnings Before Interest and Taxes9,252,0009,093,0008,977,00011,089,000
Interest Expense-777,000-707,000-655,000-704,000
Income Before Tax8,999,0007,817,0008,134,00012,272,000
Income Tax Expense1,296,0001,119,0001,106,0001,545,000
Minority Interest59,00059,00076,00078,000
Net Income From Continuing Ops7,703,0006,698,0007,028,00010,727,000
Non-recurring Events
Discontinued Operations--10,766,000-447,000
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income7,703,0006,712,00017,783,00010,210,000
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares7,703,0006,712,00017,783,00010,210,000